Skip to main content

View full-text article in PMC

. 2017 Feb 16;8(30):50124–50132. doi: 10.18632/oncotarget.15394

Table 2. Meta-analysis results of association between rs13181 A > C polymorphism and pancreatic cancer risk.

		AC vs AA		CC vs AA		AC/CC vs AA		CC vs AC/AA		C vs A
Variables	N^a	OR(95%CI)	P^b/I²(%)	OR(95%CI)	P^b/I²(%)	OR(95%CI)	P^b/I²(%)	OR(95%CI)	P^b/I²(%)	OR(95%CI)	P^b/I²(%)
Total	8	1.10(0.96-1.25)	0.636/0.0	1.56(1.28-1.90)	0.470/0.0	1.20(1.06-1.36)	0.396/4.4	1.50(1.24-1.81)	0.530/0.0	1.22(1.11-1.34)	0.159/33.7
Ethnicity
Asian	5	1.20(1.00-1.43)	0.584/0.0	1.87(1.43-2.43)	0.770/0.0	1.34(1.14-1.57)	0.534/0.0	1.74(1.35-2.25)	0.718/0.0	1.37(1.21-1.56)	0.507/0.0
Caucasian	3	0.99(0.82-1.21)	0.809/0.0	1.23(0.91-1.67)	0.681/0.0	1.04(0.86-1.25)	0.904/0.0	1.25(0.94-1.65)	0.583/0.0	1.07(0.94-1.23)	0.808/0.0
Source of controlc
PB	3	1.02(0.85-1.22)	0.707/0.0	1.25(0.95-1.65)	0.803/0.0	1.07(0.90-1.27)	0.713/0.0	1.25(0.97-1.62)	0.758/0.0	1.09(0.96-1.24)	0.661/0.0
HB	5	1.20(0.99-1.46)	0.567/0.0	1.99(1.49-2.66)	0.895/0.0	1.36(1.14-1.62)	0.568/0.0	1.85(1.39-2.45)	0.809/0.0	1.40(1.22-1.61)	0.593/0.0
HWEd
Yes	4	0.99(0.82-1.19)	0.939/0.0	1.52(1.14-2.01)	0.365/5.7	1.09(0.92-1.29)	0.853/0.0	1.53(1.17-1.99)	0.379/2.8	1.16(1.02-1.32)	0.618/0.0
No	4	1.23(1.02-1.49)	0.535/0.0	1.60(1.21-2.11)	0.339/10.7	1.33(1.11-1.58)	0.259/25.5	1.47(1.12-1.92)	0.397/0.0	1.29(1.13-1.47)	0.061/59.4

^a Number of studies;

^b P value of Q test for heterogeneity;

^c PB, population-based; HB, hospital-based;

^d HWE, Hardy-Weinberg equilibrium.